What is the current Tryptamine Therapeutics share price?
The current share price of Tryptamine Therapeutics is AUD 0.038
How many Tryptamine Therapeutics shares are in issue?
Tryptamine Therapeutics has 1,138,922,000 shares in issue
What is the market cap of Tryptamine Therapeutics?
The market capitalisation of Tryptamine Therapeutics is AUD 44.42M
What is the 1 year trading range for Tryptamine Therapeutics share price?
Tryptamine Therapeutics has traded in the range of AUD 0.017 to AUD 0.057 during the past year
What is the PE ratio of Tryptamine Therapeutics?
The price to earnings ratio of Tryptamine Therapeutics is -7.41
What is the cash to sales ratio of Tryptamine Therapeutics?
The cash to sales ratio of Tryptamine Therapeutics is 40
What is the reporting currency for Tryptamine Therapeutics?
Tryptamine Therapeutics reports financial results in AUD
What is the latest annual turnover for Tryptamine Therapeutics?
The latest annual turnover of Tryptamine Therapeutics is AUD 1.11M
What is the latest annual profit for Tryptamine Therapeutics?
The latest annual profit of Tryptamine Therapeutics is AUD -6.14M
What is the registered address of Tryptamine Therapeutics?
The registered address for Tryptamine Therapeutics is SUITE 201, 697 BURKE ROAD, CAMBERWELL, MELBOURNE, VICTORIA
What is the Tryptamine Therapeutics website address?
The website address for Tryptamine Therapeutics is tryptherapeutics.com/
Which industry sector does Tryptamine Therapeutics operate in?
Tryptamine Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
